Benjamin P. Saylor
Saylor is content managing editor for Urology Times.
European agencies follow FDA lead on T, CV risk
European agencies follow FDA lead on T, CV risk
The European Medicines Agency has issued new recommendations regarding testosterone replacement therapy after reviewing the cardiovascular risks of TRT. The recommendations were endorsed by a regulatory body that is responsible for the marketing authorization of drugs throughout Europe.
Obesity a risk factor for advanced prostate Ca
A report analyzing more than 191,000 cases of prostate cancer has found that being overweight or obese increases men’s risk for advanced prostate cancer.
Autologous pubovaginal sling shows high success rate
Autologous pubovaginal slings are associated with a high success rate following synthetic midurethral sling failure, according to recently published data.
Optimal use of bladder Ca detection agent outlined
Blue light cystoscopy with hexaminolevulinate HCl (HAL-BLC) should be considered for initial diagnosis of nonmuscle-invasive bladder cancer, an expert panel of urologists recently concluded.
Genetic test predicts prostate Ca recurrence risk
A personalized genetic test has been shown to predict risk of prostate cancer recurrence following radical prostatectomy or radiotherapy, according to a recent study.
AUA: No link between vasectomy, PCa risk
The AUA has refuted findings from a recent study that reported a modest association between vasectomy and lethal prostate cancer.
ASCO endorses adjuvant/salvage RT guideline
The American Society of Clinical Oncology has endorsed the AUA/American Society for Radiation Oncology guideline on the use of adjuvant and salvage radiotherapy after prostatectomy.
Momentum builds for female sexual dysfunction Tx
A number of prominent urologists are among the signers of a letter applauding the FDA for holding a workshop on female sexual dysfunction.
Genomic prostate score shown to predict BCR
A prostate cancer diagnostic test may have benefits beyond predicting tumor aggressiveness, a study presented at the European Society for Medical Oncology Congress showed.
July 2014 New Urology Products and Services
New urology products and services from Symtelligence Medical Informatics, LABORIE, Metamark Genetics, the MediSafe Project, and Olympus

Poll